Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oncological Safety of MRI-Informed Biopsy Decision-Making in Men With Suspected Prostate Cancer.
Hamm CA, Asbach P, Pöhlmann A, Schoots IG, Kasivisvanathan V, Henkel TO, Johannsen M, Speck T, Baur ADJ, Haas M, Collettini F, Penzkofer T, Savic LJ, Konietschke F, Weißbach L, Hamm B, König F, Cash H. Hamm CA, et al. Among authors: kasivisvanathan v. JAMA Oncol. 2024 Dec 12. doi: 10.1001/jamaoncol.2024.5497. Online ahead of print. JAMA Oncol. 2024. PMID: 39666360
Baseline Nodal Status on 68Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Intermediate- to High-risk Prostate Cancer Is Prognostic for Treatment Failure: Follow-up of the proPSMA Trial.
Hofman MS, Kasivisvanathan V, Link E, Buteau J, Roberts MJ, Francis RJ, Tang C, Vela I, Thomas P, Rutherford N, Martin JM, Frydenberg M, Shakher R, Wong LM, Taubman K, Ting Lee S, Hsiao E, Roach P, Nottage M, Kirkwood I, Hayne D, Iravani A, Williams S, O'Brien J, Lawrentschuk N, Murphy DG. Hofman MS, et al. Among authors: kasivisvanathan v. Eur Urol Oncol. 2024 Nov 28:S2588-9311(24)00251-7. doi: 10.1016/j.euo.2024.11.006. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39613566 Free article.
Understanding the long-term impact of the COVID-19 pandemic on non-muscle-invasive bladder cancer outcomes: 12-Month follow-up data from the international, prospective COVIDSurg Cancer study.
Alexander CE, Nathan A, Light A, Gao C, Chan V, Khadhouri S, Gallagher K, Byrnes KG, Walters M, Hughes T, Perry R, Okoth K, Magill L, Pinkney T, John JB, McGrath JS, Colquhoun A, Zhang Y, Blackmur J, Etchill E, Tang S, García Escudero D, Stewart G, Kasivisvanathan V; COVIDSurg Collaborative. Alexander CE, et al. Among authors: kasivisvanathan v. BJUI Compass. 2024 Oct 15;5(11):1044-1051. doi: 10.1002/bco2.432. eCollection 2024 Nov. BJUI Compass. 2024. PMID: 39539562 Free PMC article.
Follow-up on patients with initial negative mpMRI target and systematic biopsy for PI-RADS ≥ 3 lesions - an EAU-YAU study enhancing prostate cancer detection.
Zattoni F, Gandaglia G, van den Bergh RCN, Marra G, Valerio M, Martini A, Olivier J, Puche-SanzI I, Rajwa P, Maggi M, Campi R, Nicoletti R, Amparore D, De Cillis S, Zhuang J, Guo H, Fuschi A, Veccia A, Ditonno F, Paulino Pereira LJ, Marquis A, Barletta F, Leni R, Kasivisvanathan V, Antonelli A, Rivas JG, Remmers S, Roobol MJ, Briganti A, Dal Moro F, Novara G. Zattoni F, et al. Among authors: kasivisvanathan v. Prostate Cancer Prostatic Dis. 2024 Nov 5. doi: 10.1038/s41391-024-00904-1. Online ahead of print. Prostate Cancer Prostatic Dis. 2024. PMID: 39501078
Evaluating Biparametric Versus Multiparametric Magnetic Resonance Imaging for Diagnosing Clinically Significant Prostate Cancer: An International, Paired, Noninferiority, Confirmatory Observer Study.
Twilt JJ, Saha A, Bosma JS, van Ginneken B, Bjartell A, Padhani AR, Bonekamp D, Villeirs G, Salomon G, Giannarini G, Kalpathy-Cramer J, Barentsz J, Maier-Hein KH, Rusu M, Rouvière O, van den Bergh R, Panebianco V, Kasivisvanathan V, Obuchowski NA, Yakar D, Elschot M, Veltman J, Fütterer JJ, Huisman H, de Rooij M; PI-CAI Consortium. Twilt JJ, et al. Among authors: kasivisvanathan v. Eur Urol. 2024 Oct 21:S0302-2838(24)02640-X. doi: 10.1016/j.eururo.2024.09.035. Online ahead of print. Eur Urol. 2024. PMID: 39438187 Free article.
VISION: An Individual Patient Data Meta-analysis of Randomised Trials Comparing Magnetic Resonance Imaging Targeted Biopsy with Standard Transrectal Ultrasound Guided Biopsy in the Detection of Prostate Cancer.
Kasivisvanathan V, Wai-Shun Chan V, Clement KD, Levis B, Ng A, Asif A, Haider MA, Emberton M, Pond GR, Agarwal R, Scandrett K, Takwoingi Y, Klotz L, Moore CM; VISION Study Collaborators. Kasivisvanathan V, et al. Eur Urol. 2024 Sep 3:S0302-2838(24)02559-4. doi: 10.1016/j.eururo.2024.08.022. Online ahead of print. Eur Urol. 2024. PMID: 39232979 Free article. Review.
Enhancing Prostate Cancer Detection Accuracy in Magnetic Resonance Imaging-targeted Prostate Biopsy: Optimizing the Number of Cores Taken.
Zattoni F, Fasulo V, Kasivisvanathan V, Kesch C, Marra G, Martini A, Falagario U, Soeterik T, van den Bergh R, Rajwa P, Gandaglia G; EAU-YAU Prostate Cancer Working Party (PCa-WP). Zattoni F, et al. Among authors: kasivisvanathan v. Eur Urol Open Sci. 2024 Jun 24;66:16-25. doi: 10.1016/j.euros.2024.05.009. eCollection 2024 Aug. Eur Urol Open Sci. 2024. PMID: 39027654 Free PMC article. Review.
Is MRI ready to replace biopsy during active surveillance?
Dias AB, Woo S, Leni R, Rajwa P, Kasivisvanathan V, Ghai S, Haider M, Gandaglia G, Brembilla G. Dias AB, et al. Among authors: kasivisvanathan v. Eur Radiol. 2024 Dec;34(12):7716-7727. doi: 10.1007/s00330-024-10863-9. Epub 2024 Jul 4. Eur Radiol. 2024. PMID: 38965093 Review.
191 results